| Drug Name | zoptarelin doxorubicin acetate |
|---|---|
| Other Drug Names | AEZS-108; ZEN-008; D-81858; AN-152 |
| Chemical Name | [6-D-lysine]human gonadoliberin-1 (LHRH) and doxorubicin covalently linked together with glutaric acid: 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-N 6-[5-(2-{(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl}-2-oxoethoxy)-5-oxopentanoyl]-D-lysine-L-leucyl-L-arginyl-L-prolylglycinamide acetate |
| Formula | C91H117N19O26·xC2H4O2 |
| CAS No. | 1928750-34-8 |
| UNII | 4IA03SIO30 |
| Originator Company | Aeterna Zentaris GmbH |
| Structure |
 |
Extended Information